Thomas Taylor, DO
Internal Medicine · Phoenix, AZNPI 1194036566
Payments from drug & device makers
Across 41 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$118
- AstraZeneca$110
- E.r. Squibb & Sons, L.L.C.$92
- Lilly USA, LLC$49
- Johnson & Johnson$49
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$46
- plus $200 from 9 others
What the payments were for
- Food & beverage$664100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 7 | $118 |
| AstraZeneca | 8 | $110 |
| E.r. Squibb & Sons, L.L.C. | 5 | $92 |
| Lilly USA, LLC | 3 | $49 |
| Johnson & Johnson | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Novo Nordisk | 3 | $45 |
| Abbott | 1 | $37 |
| Genentech USA, Inc. | 2 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Merck | 1 | $18 |
| Pfizer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
| Novartis | 1 | $11 |
How this compares
$664 in reported general payments places this provider in the 70th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 131 | $786 |
| Potassium Chloride | 15 | $549 |
| Atorvastatin Calcium | 32 | $431 |
| Levothyroxine Sodium | 18 | $318 |
| Escitalopram Oxalate | 20 | $298 |
| Ondansetron OdtOndansetron | 22 | $285 |
| Tamsulosin Hcl | 23 | $118 |
| Amlodipine Besylate | 25 | $110 |
| Trazodone Hcl | 15 | $107 |
| Metoprolol Succinate | 17 | $88 |
| Spironolactone | 12 | $64 |
| Allopurinol | 12 | $63 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Phoenix
- Louise TaberPhoenix$8.5M
- Ernie RifferPhoenix$3M
- Frank LovecchioPhoenix$945K
- Allison PerrinPhoenix$861K
- Nasser HajaigPhoenix$687K
- Richard TayrienPhoenix$299K
- Sanjay ShahPhoenix$288K
- Kelly KrohnPhoenix$262K
- Paul WaxPhoenix$243K
- Paul StanderPhoenix$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.